ARTICLE | Clinical News
Silenor doxepin regulatory update
March 2, 2009 8:00 AM UTC
Somaxon received a complete response letter from FDA for an NDA for Silenor doxepin to treat insomnia. The company said FDA raised issues regarding the interpretation of efficacy data and asked the co...